BMO Capital Reiterates Market Perform on Pfizer (PFE) Following Investor Meetings

December 13, 2018 7:34 AM
BMO Capital analyst, Alex Arfaei, reiterated a Market Perform rating and $46.00 price target on Pfizer (NYSE: PFE) following recent ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles